ASBP

Aspire Biopharma Holdings, Inc. Common Stock

3 hedge funds and large institutions have $5.36M invested in Aspire Biopharma Holdings, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
+1
Holders Change %
+50%
% of All Funds
0.04%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.01%
New
2
Increased
1
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
HCI
1
Harraden Circle Investments
New York
$5.17M +$5.17M +449,783 New
CS
2
Clear Street
New York
$183K +$94.3K +8,199 +107%
UBS Group
3
UBS Group
Switzerland
$513 +$513 +45 New
RCM
4
Robinson Capital Management
Michigan
-$55.7K -4,490 Closed